NBM-BMX

· Novelwise Pharmaceutical Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NBM-BMX, covering 2025-11-28 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma [Phase 1, Phase 2]